Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression
- PMID: 17634564
- PMCID: PMC3595570
- DOI: 10.1097/PSY.0b013e31812f7b8e
Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression
Abstract
Objective: To investigate the relationship of cerebrovascular risk factors (CVRFs), endothelial function, carotid artery intima medial thickness (IMT), and neuropsychological performance in a sample of 198 middle-aged and older individuals with major depressive disorder (MDD). Neuropsychological deficits are common among adults with MDD, particularly among those with CVRFs and potentially persons with subclinical vascular disease.
Methods: CVRFs were indexed by the Framingham Stroke Risk Profile (FSRP) and serum cholesterol levels obtained by medical history and physical examination. Patients completed a neuropsychological test battery including measures of executive functioning, working memory, and verbal recall. Vascular function was indexed by carotid artery IMT and brachial artery flow mediated dilation (FMD). Hierarchical multiple regression analyses were used to investigate the association between CVRFs, vascular disease, and neurocognitive performance.
Results: Greater FSRP scores were associated with poorer executive functioning (b = -0.86; p = .041) and working memory (b = -0.90; p = .024). Lower high-density lipoprotein levels also were associated with poorer executive functioning (b = 1.03; p = .035). Higher IMT (b = -0.83; p = .028) and lower FMD (b = 1.29; p = .032) were associated with poorer executive functioning after controlling for CVRFs. Lower FMD was also associated with poorer working memory (b = 1.58; p = .015).
Conclusions: Greater CVRFs were associated with poorer neuropsychological performance. Vascular dysfunction also was associated with neuropsychological decrements independent of traditional CVRFs.
Figures



Similar articles
-
Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression.Am J Geriatr Psychiatry. 2010 Sep;18(9):848-52. doi: 10.1097/JGP.0b013e3181dba0fa. Am J Geriatr Psychiatry. 2010. PMID: 20808104 Free PMC article.
-
Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder.Am J Geriatr Psychiatry. 2018 Oct;26(10):1061-1069. doi: 10.1016/j.jagp.2018.06.011. Epub 2018 Jun 28. Am J Geriatr Psychiatry. 2018. PMID: 30093218 Free PMC article.
-
The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.Atherosclerosis. 2011 Dec;219(2):839-45. doi: 10.1016/j.atherosclerosis.2011.08.032. Epub 2011 Aug 25. Atherosclerosis. 2011. PMID: 21959256
-
Relationship between endothelial dysfunction, intima media thickness and cardiovascular risk factors in asymptomatic subjects.Int Angiol. 2005 Mar;24(1):52-8. Int Angiol. 2005. PMID: 15876999
-
Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis.J Hypertens. 2006 Aug;24(8):1581-8. doi: 10.1097/01.hjh.0000239294.17636.27. J Hypertens. 2006. PMID: 16877961
Cited by
-
Executive functions in elderly men.Age (Dordr). 2012 Feb;34(1):59-66. doi: 10.1007/s11357-011-9215-7. Epub 2011 Feb 19. Age (Dordr). 2012. PMID: 21336568 Free PMC article.
-
Psychosocial risk and management of physical diseases.J Behav Med. 2019 Feb;42(1):16-33. doi: 10.1007/s10865-018-00007-y. Epub 2019 Jan 10. J Behav Med. 2019. PMID: 30632000 Free PMC article. Review.
-
Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression.Am J Geriatr Psychiatry. 2010 Sep;18(9):848-52. doi: 10.1097/JGP.0b013e3181dba0fa. Am J Geriatr Psychiatry. 2010. PMID: 20808104 Free PMC article.
-
Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.Schizophr Res. 2015 May;164(1-3):115-21. doi: 10.1016/j.schres.2015.02.006. Epub 2015 Feb 23. Schizophr Res. 2015. PMID: 25728832 Free PMC article.
-
Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial.J Alzheimers Dis. 2020;77(4):1793-1803. doi: 10.3233/JAD-200374. J Alzheimers Dis. 2020. PMID: 32925039 Free PMC article. Clinical Trial.
References
-
- Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999;30:2523–8. - PubMed
-
- Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary-care patients. Ann Intern Med. 1995;122:422–9. - PubMed
-
- Elias PK, Elias MF, Dagostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance—the Framingham study. Diabetes Care. 1997;20:1388–95. - PubMed
-
- Muldoon MF, Ryan CM, Matthews KA, Manuck SB. Serum cholesterol and intellectual performance. Psychosom Med. 1997;59:382–7. - PubMed
-
- Elias MF, Sullivan LM, D’Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004;35:404–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical